Previously, the deletion of the MIR21 gene locus by TALEN and CRISPR/Cas9 technologies revealed a substantially impaired oncogenic potential of HeLa cells and independent, oncogenic roles of miR-21-5p/3p in squamous cell carcinoma stem cells (37,38). The gene discussed is MIR21; the disease is squamous cell carcinoma.